Key question during medication review
Fourteen months after the cough began, Linda was preparing for psychiatric evaluation when a new physician reviewed her history. The consultation focused on a single question that had not been fully explored: What medications are you taking? In addition to lifestyle details and past test results, the list revealed an angiotensin-converting enzyme (ACE) inhibitor prescribed for hypertension.
ACE inhibitors are widely used and generally well tolerated, yet clinical studies indicate that 5 to 25 percent of patients experience a chronic dry cough. The reaction is reported more frequently in women and in nonsmokers, and it may surface weeks, months, or even years after therapy begins. The effect is not consistently related to dose; genetically susceptible patients can react to even minimal amounts.
Confirming the suspected culprit
The simplest way to test whether an ACE inhibitor is responsible for coughing is to stop the drug and replace it with a different class of antihypertensive medicine. Linda’s prescription was switched to a calcium channel blocker. Within one week the nocturnal cough vanished completely, and uninterrupted sleep returned for the first time in over a year. As rest improved, her anxiety and depressive symptoms receded without additional psychiatric treatment, and her blood pressure remained controlled.
Physiological mechanism
Research suggests that ACE inhibitors raise circulating levels of bradykinin and related peptides, lowering the threshold of the cough reflex. In sensitive individuals, ordinary environmental stimuli that would not normally provoke coughing can trigger persistent bouts. The mechanism operates independently of drug dosage, so reducing the amount rarely solves the problem; discontinuation is typically required.
An overview by the U.S. National Library of Medicine lists chronic cough as a recognized adverse effect and recommends notifying a physician if it occurs. In most documented cases, symptoms resolve within days to a few weeks after withdrawal, and re-exposure to the same drug often reproduces the cough, further confirming causality.
Broader implications for clinical practice
Linda’s experience underscores the importance of complete medication review whenever symptoms remain unexplained. Extensive imaging, endoscopy, and laboratory testing can fail to detect pharmacological side effects, especially when those effects appear long after treatment initiation. Without identifying the root cause, patients may be labeled with functional disorders, receive unnecessary therapies, or be referred for psychiatric care that addresses secondary distress rather than the primary trigger.
Similar oversights have been documented in cases where ACE inhibitors were hidden within combination pills, making the connection even easier to miss. Systematic verification of every prescription, over-the-counter product, and supplement can prevent misdiagnosis, reduce patient suffering, and lower healthcare costs by eliminating redundant investigations.
Intersection of physical and mental health
Persistent physical symptoms frequently generate emotional consequences. Anxiety and depression that arise under such conditions are often adaptive responses to unresolved discomfort, uncertainty, and sleep disruption. Treating the emotional fallout without resolving the physical cause may provide partial relief but rarely eliminates the problem. Conversely, identifying and removing the physical trigger can diminish psychological distress without additional psychotropic medication.
For clinicians, the case highlights a simple yet critical principle: before declaring a symptom idiopathic or psychosomatic, review every drug the patient takes, even those started long before the complaint began. Sometimes the solution is not another diagnostic test but one more question.